PD184352
Synonym(s):2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide;CI-1040
- CAS NO.:212631-79-3
- Empirical Formula: C17H14ClF2IN2O2
- Molecular Weight: 478.66
- MDL number: MFCD02683961
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 23:13:44
What is PD184352?
Chemical properties
Off-White to Pale Beige Solid
The Uses of PD184352
An inhibitor of ERK signaling pathway. A MAP kinase inhibitor
The Uses of PD184352
An inhibitor of ERK signaling pathway. A MAP kinase inhibitor. Potent MEK inhibitor.
What are the applications of Application
PD 184,352 is a MEK inhibitor
Definition
ChEBI: 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide is an aminobenzoic acid.
Biological Activity
pd184352 (also known as ci-1040), a benzhydroxamate derivative, is a potent and highly selective mek1/2, two members of the family of mapkks, inhibitor that inhibits purified mek1 with ic50 of 17 nm in a non-atp and non-erk1/2 competitive manner [1].pd184352 binds to a hydrophobic pocket, which is located in a region with low sequence homology to other kinases, adjacent to the mg-atp binding site of mek1 and mek2 inducing a conformational change in un-phosphorylated mek1/2 and hence inactivating the un-phosphorylated mek1/2 [1].pd184352 has been found to be actively against tumors, where it inhibits the growth of colon carcinomas in mouse xenograft models [1].
Biochem/physiol Actions
PD184352 (CI-1040) is a highly selective non-competitive inhibitor of MEK (MKK1; MAPK kinase) and the closely related MKK2. It has anti-cancer activity, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell lines.
Storage
Store at +4°C
References
[1] frémin c, meloche s. from basic research to clinical development of mek1/2 inhibitors for cancer therapy. j hematol oncol. 2010 feb 11;3:8. doi: 10.1186/1756-8722-3-8.
Properties of PD184352
| Melting point: | 166-169°C |
| Density | 1.747±0.06 g/cm3(Predicted) |
| storage temp. | room temp |
| solubility | DMSO: ≥30mg/mL |
| pka | -5.58±0.50(Predicted) |
| form | powder |
| color | white to tan |
Safety information for PD184352
| Signal word | Warning |
| Pictogram(s) |
![]() Environment GHS09 |
| GHS Hazard Statements |
H400:Hazardous to the aquatic environment, acute hazard |
| Precautionary Statement Codes |
P273:Avoid release to the environment. |
Computed Descriptors for PD184352
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineRelated products of tetrahydrofuran








You may like
-
PD184352 98% (HPLC) CAS 212631-79-3View Details
212631-79-3 -
PD 184352 CAS 212631-79-3View Details
212631-79-3 -
PD184352 CAS 212631-79-3View Details
212631-79-3 -
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
118-23-0 NLT 95%View Details
118-23-0 -
573704-41-3 NLT 95%View Details
573704-41-3

